Economic evaluations of smoking interventions

Preventive Medicine

Volumn 26, Issue 2, 1997, Pages 271-273

  Cheung, A M ^a   Tsevat, J ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

CORONARY ARTERY DISEASE; COST CONTROL; DRUG COST; HEALTH CARE DELIVERY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTRANASAL DRUG ADMINISTRATION; LUNG DISEASE; NOTE; PATIENT COUNSELING; PRIORITY JOURNAL; RISK FACTOR; SMOKING CESSATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0030891559     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1006/pmed.1996.0126     Document Type: Editorial

References (20)

1. GW Torrance JE Siegel BR Luce Framing and designing the cost-effectiveness analysis Cost-effectiveness in health and medicine 1996 Oxford Univ. Press New York p. 54–81
2. C Silagy D Mant G Fowler M Lodge Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation Lancet 343 1994 139 142
3. JL Tang M Law N Wald How effective is nicotine replacement therapy in helping people to stop smoking BMJ 308 1994 21 26
4. MC Fiore SS Smith EJ Douglas TB Baker The effectiveness of the nicotine patch for smoking cessation JAMA 271 1994 1940 1947
5. MA Wasley SE McNagny VL Phillips JS Ahluwalia The cost-effectiveness of the nicotine transdermal patch for smoking cessation Prev Med 26 1997 264 270
6. K Fiscella P Franks Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling JAMA 275 1996 1247 1251
7. G Oster DM Huse TE Delea GA Colditz Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smoking JAMA 256 1986 1315 1318
8. RL Akehurst J Piercy Cost-effectiveness of the use of transdermal Nicorette patches relative to GP counseling and nicotine gum in the prevention of smoking-related diseases Br J Med Econ 7 1994 115 122
9. RL Akehurst J Piercy Cost-effectiveness of the use of Nicorette nasal spray to assist quitting smoking among heavy smokers Br J Med Econ 7 1994 155 184
10. A, M, Cheung, J, Tsevat, The economic impact of smoking and smoking cessation, Am J Med
11. G Sutherland JA Stapleton AH Russell MJ Jarvis P Hajek M Belcher C Feyerabend Randomized controlled trial of nicotine nasal spray in smoking cessation Lancet 340 1992 324 329
12. A Hjalmarson M Franzon A Westin O Wiklund Effect of nicotine nasal spray on smoking cessation: a randomized, placebo-controlled, double-blind study Arch Intern Med 154 1994 2567 2572
13. HM Krumholz BJ Cohen J Tsevat RC Pasternak MC Weinstein Cost-effectiveness of a smoking cessation program after myocardial infarction J Am Coll Cardiol 22 1993 1697 1702
14. SR Cummings SM Rubin G Oster The cost-effectiveness of counseling smokers to quit JAMA 261 1989 75 79
15. BR Luce WG Manning JE Siegel J Lipscomb Estimating costs in cost-effectiveness analysis MR Gold JE Siegel LB Russell MC Weinstein Cost-effectiveness in health and medicine 1996 Oxford Univ. Press New York 176 213
16. JT Edelson MC Weinstein A NA Tosteson LW Williams TH Lee L Goldman Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension JAMA 263 1990 408 413
17. AA Stinnett MA Mittleman MC Weinstein KM Kuntz DJ Cohen LW Williams The cost-effectiveness of dietary and pharmacologic therapy for cholesterol reduction in adults MR Gold JE Siegel LB Russell MC Weinstein Cost-effectiveness in health and medicine 1996 Oxford Univ. Press New York 349 391
18. MMWR 43 1994 342 346
19. JP Pierce MC Fiore TE Novotny EJ Hatziandreu RM Davis Trends in cigarette smoking in the United States: projections to the year 2000 JAMA 261 1989 61 65
20. MMWR 44 1995 521 525